| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1020839102 |
| P356 | DOI | 10.1007/S00330-010-1977-2 |
| P953 | full work available at URL | http://link.springer.com/article/10.1007/s00330-010-1977-2/fulltext.html |
| http://link.springer.com/content/pdf/10.1007/s00330-010-1977-2.pdf | ||
| http://link.springer.com/content/pdf/10.1007/s00330-010-1977-2 | ||
| P698 | PubMed publication ID | 20886339 |
| P2093 | author name string | M. Pech | |
| J. Ricke | |||
| S. Kropf | |||
| F. Fischbach | |||
| D. Löwenthal | |||
| M. Zeile | |||
| C. Wybranski | |||
| W. Y. Lim | |||
| G. Wieners | |||
| O. Dudeck | |||
| P2860 | cites work | Magnetic resonance quarterly | Q27709722 |
| Molecular diffusion nuclear magnetic resonance imaging | Q33569577 | ||
| Improved detection of focal liver lesions at MR imaging: multicenter comparison of gadoxetic acid-enhanced MR images with intraoperative findings | Q35616266 | ||
| Efficacy and safety of MR imaging with liver-specific contrast agent: U.S. multicenter phase III study | Q36242731 | ||
| New MR techniques for the detection of liver metastases | Q36502861 | ||
| MR imaging in patients with suspected liver metastases: value of liver-specific contrast agent Gd-EOB-DTPA. | Q36825568 | ||
| Focal liver lesion detection and characterization with diffusion-weighted MR imaging: comparison with standard breath-hold T2-weighted imaging | Q37068523 | ||
| Diffusion-weighted magnetic resonance imaging as a cancer biomarker: consensus and recommendations. | Q37073257 | ||
| Clinical value of MRI liver-specific contrast agents: a tailored examination for a confident non-invasive diagnosis of focal liver lesions | Q37276760 | ||
| Consensus report of the 2nd International Forum for Liver MRI. | Q37620213 | ||
| Resection of hepatic metastases from colorectal cancer. Biologic perspective | Q38671141 | ||
| Guidelines for resection of colorectal cancer liver metastases. | Q42150472 | ||
| Diagnosis of liver metastases: value of diffusion-weighted MRI compared with gadolinium-enhanced MRI. | Q44206380 | ||
| Detection of colorectal hepatic metastases using MnDPDP MR imaging and diffusion-weighted imaging (DWI) alone and in combination. | Q46809564 | ||
| Dynamic MR imaging of liver metastases with Gd-EOB-DTPA. | Q52077166 | ||
| Enhancement characteristics of liver metastases, hepatocellular carcinomas, and hemangiomas with Gd-EOB-DTPA: preliminary results with dynamic MR imaging. | Q53003385 | ||
| High spatial resolution T1-weighted MR imaging of liver and biliary tract during uptake phase of a hepatocyte-specific contrast medium. | Q53390842 | ||
| Superparamagnetic iron oxide (SPIO)-enhanced liver MRI with ferucarbotran: efficacy for characterization of focal liver lesions. | Q53496562 | ||
| Hepatic cavernous hemangiomas: simple diagnostic sign with dynamic bolus CT | Q67735206 | ||
| Liver tumors: comparison of MR imaging with Gd-EOB-DTPA and Gd-DTPA | Q71134310 | ||
| Hepatic hemangiomas: a multi-institutional study of appearance on T2-weighted and serial gadolinium-enhanced gradient-echo MR images | Q72056093 | ||
| Spectrum of MRI appearances of untreated metastases of the liver | Q73838289 | ||
| Contrast-enhanced MRI of focal liver tumors using a hepatobiliary MR contrast agent: detection and differential diagnosis using Gd-EOB-DTPA-enhanced versus Gd-DTPA-enhanced MRI in the same patient | Q74133713 | ||
| Diagnosis of hepatic metastasis: comparison of respiration-triggered diffusion-weighted echo-planar MRI and five t2-weighted turbo spin-echo sequences | Q79674880 | ||
| Diagnostic efficacy of gadoxetic acid (Primovist)-enhanced MRI and spiral CT for a therapeutic strategy: comparison with intraoperative and histopathologic findings in focal liver lesions | Q80143855 | ||
| Respiratory gated diffusion-weighted imaging of the liver: value of apparent diffusion coefficient measurements in the differentiation between most commonly encountered benign and malignant focal liver lesions | Q81579499 | ||
| Hepatic metastases: diffusion-weighted sensitivity-encoding versus SPIO-enhanced MR imaging | Q82625559 | ||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | colorectal carcinoma | Q25493920 |
| P304 | page(s) | 832-840 | |
| P577 | publication date | 2010-10-02 | |
| P1433 | published in | European Radiology | Q5413071 |
| P1476 | title | Detection and characterisation of focal liver lesions in colorectal carcinoma patients: comparison of diffusion-weighted and Gd-EOB-DTPA enhanced MR imaging | |
| P478 | volume | 21 |
| Q52984886 | A meta-analysis of diffusion-weighted and gadoxetic acid-enhanced MR imaging for the detection of liver metastases. |
| Q55362832 | Apparent diffusion coefficient of hepatocellular carcinoma on diffusion-weighted imaging: Histopathologic tumor grade versus arterial vascularity during dynamic magnetic resonance imaging. |
| Q36319700 | Characterization of focal liver lesions using quantitative techniques: comparison of apparent diffusion coefficient values and T2 relaxation times |
| Q36747357 | Colorectal liver metastases: disappearing lesions in the era of Eovist hepatobiliary magnetic resonance imaging. |
| Q36326141 | Combining diffusion-weighted MRI with Gd-EOB-DTPA-enhanced MRI improves the detection of colorectal liver metastases |
| Q28088807 | Consensus report from the 7th International Forum for Liver Magnetic Resonance Imaging |
| Q37314146 | Cost evaluation of gadoxetic acid-enhanced magnetic resonance imaging in the diagnosis of colorectal-cancer metastasis in the liver: Results from the VALUE Trial |
| Q84632253 | Detection of liver metastasis: is diffusion-weighted imaging needed in Gd-EOB-DTPA-enhanced MR imaging for evaluation of colorectal liver metastases? |
| Q37129627 | Diagnostic Accuracy of Preoperative Gadoxetic Acid-enhanced 3-T MR Imaging for Malignant Liver Lesions by Using Ex Vivo MR Imaging-matched Pathologic Findings as the Reference Standard |
| Q91998214 | Diagnostic value/performance of radiological liver imaging during chemoterapy for gastrointestinal malignancy: a critical review |
| Q53156555 | Differential diagnosis between hepatic metastases and benign focal lesions using DWI with parallel acquisition technique: a meta-analysis. |
| Q86823493 | Diffusion-weighted MRI for uveal melanoma liver metastasis detection |
| Q36166572 | Diffusion-weighted MRI in a liver protocol: its role in focal lesion detection |
| Q39186073 | Diffusion-weighted and T2-weighted MR imaging for colorectal liver metastases detection in a rat model at 7 T: a comparative study using histological examination as reference. |
| Q28069103 | Diffusion-weighted imaging of the liver: Current applications |
| Q38100027 | Diffusion-weighted imaging of the liver: an update. |
| Q30840354 | Diffusion-weighted imaging of the liver: techniques and applications |
| Q63366773 | Diffusion-weighted magnetic resonance imaging in the prediction and assessment of chemotherapy outcome in liver metastases |
| Q28066171 | FIRST BRAZILIAN CONSENSUS ON MULTIMODAL TREATMENT OF COLORECTAL LIVER METASTASES. MODULE 1: PRE-TREATMENT EVALUATION |
| Q87162531 | Gadoxetic acid-enhanced MRI and diffusion-weighted imaging for the detection of colorectal liver metastases after neoadjuvant chemotherapy |
| Q60928781 | Gd-EOB-DTPA dynamic contrast-enhanced magnetic resonance imaging is more effective than enhanced 64-slice CT for the detection of small lesions in patients with hepatocellular carcinoma |
| Q36688101 | Gd-EOB-DTPA-Enhanced MR Imaging of the Liver: The Effect on T2 Relaxation Times and Apparent Diffusion Coefficient (ADC) |
| Q36802087 | Gd-EOB-DTPA-Enhanced MRI for Detection of Liver Metastases from Colorectal Cancer: A Surgeon's Perspective! |
| Q36352452 | Hepatic imaging response to radioembolization with yttrium-90-labeled resin microspheres for tumor progression during systemic chemotherapy in patients with colorectal liver metastases |
| Q56741838 | Hypervascular hepatocellular carcinomas: detection with gadoxetate disodium-enhanced MR imaging and multiphasic multidetector CT |
| Q92633773 | Imaging of Colorectal Liver Metastases: New Developments and Pending Issues |
| Q28731628 | Implementation of dual-source RF excitation in 3 T MR-scanners allows for nearly identical ADC values compared to 1.5 T MR scanners in the abdomen |
| Q36091564 | Is neoadjuvant chemotherapy necessary for patients with initially resectable colorectal liver metastases in the era of effective chemotherapy? |
| Q38348770 | Lesion discrimination with breath-hold hepatic diffusion-weighted imaging: a meta-analysis |
| Q38698232 | Liver metastasis is established by metastasis of micro cell aggregates but not single cells |
| Q37329995 | MR imaging in patients with suspected liver metastases: value of liver-specific contrast agent gadoxetic acid |
| Q36201171 | MR liver imaging with Gd-EOB-DTPA: a delay time of 10 minutes is sufficient for lesion characterisation |
| Q48203418 | Magnetic resonance with diffusion-weighted imaging improves assessment of focal liver lesions in patients with potentially resectable pancreatic cancer on CT. |
| Q41371065 | Meta-analysis of gadoxetic acid disodium (Gd-EOB-DTPA)-enhanced magnetic resonance imaging for the detection of liver metastases |
| Q26798428 | Non-invasive diagnostic imaging of colorectal liver metastases |
| Q26822764 | Noninvasive diagnosis of hepatocellular carcinoma in cirrhotic liver: current guidelines and future prospects for radiological imaging |
| Q26753854 | Perioperative treatment options in resectable pancreatic cancer - how to improve long-term survival |
| Q36208221 | Preoperative imaging of colorectal liver metastases after neoadjuvant chemotherapy: a meta-analysis |
| Q35035082 | Randomized multicentre trial of gadoxetic acid-enhanced MRI versus conventional MRI or CT in the staging of colorectal cancer liver metastases |
| Q30448049 | Recent Advances in CT and MR Imaging for Evaluation of Hepatocellular Carcinoma |
| Q30415026 | Selection for hepatic resection of colorectal liver metastases: expert consensus statement |
| Q84971980 | Staging of colorectal liver metastases after preoperative chemotherapy. Diffusion-weighted imaging in combination with Gd-EOB-DTPA MRI sequences increases sensitivity and diagnostic accuracy |
| Q35285305 | Update on the role of imaging in management of metastatic colorectal cancer |
| Q30669419 | Use of contrast agents in oncological imaging: magnetic resonance imaging |
| Q89471029 | [Importance of diffusion imaging in liver metastases] |
| Q52984190 | [Pancreatic neuroendocrine neoplasms]. |
Search more.